Price movement over the last 24 hours
ARK Genomic Revolution ETF vs Amplify Transformational Data Sharing ETF — how do they compare? ARK Genomic Revolution ETF trades at $40.95, while Amplify Transformational Data Sharing ETF trades at $61.87. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Amplify Transformational Data Sharing ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | BLOK | |
|---|---|---|
Sector | Sector/Thematic | — |
52-Week High | $43.57 | $74.10 |
52-Week Low | $23.09 | $47.36 |
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
BLOK trades at $62.66, down 1.2% with bearish technical signals from moving averages and oscillators. The stock faces resistance at $63 and support at $61. Recent news highlights the ETF's diversified blockchain economy exposure, though analyst sentiment has turned cautious due to increased bitcoin-linked exposure reducing diversification benefits.
Outlook remains mixed with technical weakness but strategic positioning in blockchain infrastructure. Key risks include crypto market volatility and reduced diversification. Investment opportunity exists for long-term exposure to blockchain technology growth, balanced against near-term technical headwinds and sector concentration concerns.
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →The fund is an actively managed ETF that seeks to provide total return by investing at least 80% of its net assets in the equity securities of companies actively involved in the development and utilization of "transformational data sharing technologies". It may invest in non-US equity securities, including depositary receipts.
Read more on BLOK →